"Heart Failure, Systolic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
Concept/Terms
Heart Failure, Systolic- Heart Failure, Systolic
- Heart Failures, Systolic
- Systolic Heart Failures
- Systolic Heart Failure
Below are MeSH descriptors whose meaning is more general than "Heart Failure, Systolic".
Below are MeSH descriptors whose meaning is more specific than "Heart Failure, Systolic".
This graph shows the total number of publications written about "Heart Failure, Systolic" by people in Harvard Catalyst Profiles by year, and whether "Heart Failure, Systolic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 2 | 3 |
2009 | 1 | 2 | 3 |
2010 | 6 | 0 | 6 |
2011 | 6 | 1 | 7 |
2012 | 5 | 1 | 6 |
2013 | 5 | 1 | 6 |
2014 | 2 | 0 | 2 |
2015 | 11 | 2 | 13 |
2016 | 3 | 0 | 3 |
2017 | 6 | 0 | 6 |
2018 | 10 | 1 | 11 |
2019 | 0 | 1 | 1 |
2020 | 2 | 0 | 2 |
2021 | 6 | 0 | 6 |
2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Heart Failure, Systolic" by people in Profiles.
-
Depression Subtypes in Systolic Heart Failure: A Secondary Analysis From a Randomized Controlled Trial. J Acad Consult Liaison Psychiatry. 2023 Sep-Oct; 64(5):444-456.
-
Incidence, predictors and outcomes of new onset systolic heart failure following orthotopic liver transplant: A systematic review. Transplant Rev (Orlando). 2023 04; 37(2):100758.
-
Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study. Circ Heart Fail. 2023 Jan; 16(1):e009745.
-
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF. Clin Res Cardiol. 2022 Apr; 111(4):440-450.
-
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial. J Am Coll Cardiol. 2021 09 28; 78(13):1321-1332.
-
Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care. Heart. 2021 09; 107(17):1407-1416.
-
Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur Heart J. 2021 05 21; 42(20):2000-2011.
-
The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF). Eur J Heart Fail. 2021 06; 23(6):1052-1056.
-
Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study. Heart Rhythm. 2021 06; 18(6):977-986.
-
Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure. JACC Heart Fail. 2021 03; 9(3):226-236.